Abiopharma

Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update

Lantronix to Report Fiscal 2026 Fourth Quarter Results on Aug. 26, 2026

Biomea Fusion Announces First Patient Dosed in OPAL Study Evaluating Icovamenib in Combination with Semaglutide in Obesity

NMG présente le bilan du T2 2026 et souligne un trimestre charnière marqué par la transition du développement à l’exécution de la mine Matawinie

E-STORAGEs KuBank 3.0 for C&I Applications Successfully Passes Large-Scale Fire Testing

Legence Reports Second Quarter 2026 Financial Results

General Announcement: 1H2026 Results Briefing

Share Buy Back - Daily Share Buy-Back Notice: S$2Bn Value Realisation Share Buy-back Programme

Paysafe Reports Second Quarter 2026 Results

Brookfield Wealth Solutions Announces Strong Second Quarter Results